Speaker

Home•Speakers•Eric Dy

Eric Dy

Co-Founder and CEO, Bloomlife

Eric Dy, PhD is co-founder and CEO of Bloomlife, a women’s health company designing remote prenatal care solutions to improve the health of women and babies.

Eric brings unique perspective on the opportunities and challenges in emerging healthcare technologies and delivery models informed by multidisciplinary technical expertise leading business development for Europe’s leading R&D institute, imec.

Eric earned his BSc in Bioengineering from Cornell and his MSc and PhD in Biomedical Engineering from UCLA.

Bloomlife has been recognized for their pioneering work winning Fast Company World Changing Ideas, Johnson & Johnson Quickfire Challenge, Richard Branson’s Extreme Tech Challenge, MedTech Innovator Award, and speaking at the White House Precision Public Health Summit.

AllSessions

Day 1
May 26, 2021
5:45 pm

RoundTable: Gathering Female Specific Data by Innovative Means

This session will cover the innovative ways companies are going about collecting gender specific data in order to: close the data gap and have a better understanding of female specific metrics; ....Eric Dy, CEO + Co-Founder of Bloom Life: remote personalised maternal and fetal healthcare....... Marina Pavlovic Rivas, CEO + Co-Founder of Eli Health: a product monitoring hormones in saliva at home to enable women to make informed decisions about their reproductive and general health........ Dr. Shruthi Mahalingaiah, Principle Investigator on the Apple Women’s Health Study: the Harvard T.H. Chan School of Public Health has teamed up with Apple and the National Institute of Environmental Health Sciences (NIEHS) to gain a deeper understanding of how certain demographic and lifestyle factors could have an impact on menstrual cycles and gynecologic conditions.................... Laura Symul, Postdoctoral Fellow at Stanford, whose research focuses on women’s health and menstrual health, using a combination of self-tracked data from mobile phone apps and devices and clinical multi-omics data.
Eric DySarah KerruishMarina Pavlovic RivasLaura Symul
26 May
Time:  5:45 pm - 7:15 pm
Location:  This session will cover the innovative ways companies are going about collecting gender specific data in order to: close the data gap and have a better understanding of female specific metrics; ....Eric Dy, CEO + Co-Founder of Bloom Life: remote personalised maternal and fetal healthcare....... Marina Pavlovic Rivas, CEO + Co-Founder of Eli Health: a product monitoring hormones in saliva at home to enable women to make informed decisions about their reproductive and general health........ Dr. Shruthi Mahalingaiah, Principle Investigator on the Apple Women’s Health Study: the Harvard T.H. Chan School of Public Health has teamed up with Apple and the National Institute of Environmental Health Sciences (NIEHS) to gain a deeper understanding of how certain demographic and lifestyle factors could have an impact on menstrual cycles and gynecologic conditions.................... Laura Symul, Postdoctoral Fellow at Stanford, whose research focuses on women’s health and menstrual health, using a combination of self-tracked data from mobile phone apps and devices and clinical multi-omics data.
Speaker:  Eric DySarah KerruishMarina Pavlovic RivasLaura Symul
Day I
June 1, 2022
5:30 pm

RoundTable: The Gender Data Gap

The Gender Data Gap persists at every echelon of healthcare from trials to treatment. Some examples? 70% of the people affected by chronic pain conditions are women – but 80% of research into pain is conducted on male humans or rodents. Despite being the leading cause of mortality in women, diagnosis of heart disease and models of clinical care draw heavily on previous research conducted only with men. The vaginal microbiome is another example. It is associated with the risk for STIs, Pelvic inflammatory disease, Fertility issues or failed IVF cycles, Pregnancy complications such as miscarriage, preterm birth, neonatal problems, and preeclampsia and much more. And yet, though lots of resources have been invested in understanding other human microbiomes like gut or skin microbiomes, when it comes to the vagina, the microbiome has been overlooked.
Priyanka JainAnna LeeDr. Yana AznavourEric Dy
1 June
Time:  5:30 pm - 6:30 pm
Location:  The Gender Data Gap persists at every echelon of healthcare from trials to treatment. Some examples? 70% of the people affected by chronic pain conditions are women – but 80% of research into pain is conducted on male humans or rodents. Despite being the leading cause of mortality in women, diagnosis of heart disease and models of clinical care draw heavily on previous research conducted only with men. The vaginal microbiome is another example. It is associated with the risk for STIs, Pelvic inflammatory disease, Fertility issues or failed IVF cycles, Pregnancy complications such as miscarriage, preterm birth, neonatal problems, and preeclampsia and much more. And yet, though lots of resources have been invested in understanding other human microbiomes like gut or skin microbiomes, when it comes to the vagina, the microbiome has been overlooked.
Speaker:  Priyanka JainAnna LeeDr. Yana AznavourEric Dy